CARPHA performs a PCR assay using the Xpert MTB/RIF test (for use with the Cepheid GeneXpert® System). This is a semi-quantitative nested real-time PCR in-vitro diagnostic test for:
The MTB/RIF test is intended for use with specimens from untreated patients for whom there is clinical suspicion of tuberculosis (TB). Use of Xpert MTB/RIF for detection of M. tuberculosis (MTB) or determination of rifampicin susceptibility has not been validated for patients who are receiving treatment for tuberculosis.
Copyright 2022 by The Caribbean Public Health Agency